Professor Richard Adams
Prosiectau fel Prif Ymchwiliwr
- Access to AML data (01.08.2015 - 30.04.2018)
- Adults with acute myeloid leukaemia or high-risk myelodysplastic syndrome (16.09.2015 - 31.08.2025)
- Adults with acute myeloid leukaemia or high risk myelodysplastic syndrome - AML19
(30.07.2015 - 31.07.2022) - AML 17 Supply agreement (29.04.2009 - 15.11.2019)
- AML 18 - A trial for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome (01.06.2013 - 31.07.2024)
Prosiectau fel Cyd-Ymchwiliwr
- Adjuvant radiotherapy in patients with high-risk primary cutaneous
Squamous Cell Carcinoma AFTER surgery (SCC-AFTER): an open label, multicentre, two-arm phase III randomised trial01.01.2023 - AML pick a winner programme (Ll-1 Trial) (10.01.2014 - 30.06.2021)
- A phase 2 study of the monocyte-targeted histone deacetylase inhibitor tefinostat in chronic myelomonocytic leukaemia01.07.201530.11.2019
- A programme of development for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome (01.02.2013 - 31.01.2020)
- Arthritis Research UK Treatment Centre (01.08.2012 - 30.09.2020)